KEGG   PATHWAY: vlg05210
Entry
vlg05210                    Pathway                                
Name
Colorectal cancer - Vulpes lagopus (Arctic fox)
Description
Colorectal cancer (CRC) is the second largest cause of cancer-related deaths in Western countries. CRC arises from the colorectal epithelium as a result of the accumulation of genetic alterations in defined oncogenes and tumour suppressor genes (TSG). Two major mechanisms of genomic instability have been identified in sporadic CRC progression. The first, known as chromosomal instability (CIN), results from a series of genetic changes that involve the activation of oncogenes such as K-ras and inactivation of TSG such as p53, DCC/Smad4, and APC. The second, known as microsatellite instability (MSI), results from inactivation of the DNA mismatch repair genes MLH1 and/or MSH2 by hypermethylation of their promoter, and secondary mutation of genes with coding microsatellites, such as transforming growth factor receptor II (TGF-RII) and BAX. Hereditary syndromes have germline mutations in specific genes (mutation in the tumour suppressor gene APC on chromosome 5q in FAP, mutated DNA mismatch repair genes in HNPCC).
Class
Human Diseases; Cancer: specific types
Pathway map
vlg05210  Colorectal cancer
vlg05210

Organism
Vulpes lagopus (Arctic fox) [GN:vlg]
Gene
121489623  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
121486746  AXIN1; axin-1 isoform X1 [KO:K02157]
121473774  AXIN2; axin-2 isoform X1 [KO:K04385]
121478755  CTNNB1; catenin beta-1 [KO:K02105]
121489860  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
121495587  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
121495797  TCF7; transcription factor 7 isoform X1 [KO:K02620]
121490511  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
121485032  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
121493895  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
121499098  MYC; myc proto-oncogene protein isoform X1 [KO:K04377]
121501724  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
121479900  KRAS; GTPase KRas isoform X1 [KO:K07827]
121477352  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
121478805  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
121499678  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
121481416  phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
121496480  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
121494738  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
121488903  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
121482033  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
121482375  LOW QUALITY PROTEIN: RAC-gamma serine/threonine-protein kinase-like [KO:K04456] [EC:2.7.11.1]
121493415  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
121501608  BAD; bcl2-associated agonist of cell death [KO:K02158]
121498045  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
121483180  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
121489076  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
121494281  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
121484067  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
121495470  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
121475510  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
121486545  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
121500205  JUN; transcription factor AP-1 [KO:K04448]
121493811  FOS; proto-oncogene c-Fos [KO:K04379]
121473707  RALGDS; ral guanine nucleotide dissociation stimulator isoform X1 [KO:K08732]
121471412  RALA; ras-related protein Ral-A [KO:K07834]
121482021  RALB; ras-related protein Ral-B [KO:K07835]
121486443  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
121479474  ras-related C3 botulinum toxin substrate 1-like [KO:K04392]
121490389  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
121473005  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
121494185  RHOA; transforming protein RhoA [KO:K04513]
121482830  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
121493739  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
121494640  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
121481790  DCC; netrin receptor DCC isoform X1 [KO:K06765]
121489913  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
121494884  APPL1; DCC-interacting protein 13-alpha isoform X1 [KO:K08733]
121485274  TGFB1; transforming growth factor beta-1 proprotein isoform X1 [KO:K13375]
121471376  TGFB2; transforming growth factor beta-2 proprotein isoform X1 [KO:K13376]
121493196  TGFB3; transforming growth factor beta-3 proprotein [KO:K13377]
121495382  TGFBR1; TGF-beta receptor type-1 isoform X1 [KO:K04674] [EC:2.7.11.30]
121478523  TGFBR2; TGF-beta receptor type-2 isoform X1 [KO:K04388] [EC:2.7.11.30]
121484675  SMAD2; mothers against decapentaplegic homolog 2 [KO:K04500]
121482745  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
121482063  SMAD4; mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501]
121478870  MLH1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
121492051  MSH2; DNA mismatch repair protein Msh2 [KO:K08735]
121489321  MSH3; DNA mismatch repair protein Msh3 [KO:K08736]
121490534  MSH6; DNA mismatch repair protein Msh6 isoform X1 [KO:K08737]
121484229  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
121481985  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
121491466  BCL2L11; bcl-2-like protein 11 isoform X1 [KO:K16341]
121485860  BBC3; bcl-2-binding component 3 [KO:K10132]
121481811  BCL2; apoptosis regulator Bcl-2 isoform X1 [KO:K02161]
121480404  cytochrome c-like [KO:K08738]
121488803  cytochrome c-like [KO:K08738]
121482342  cytochrome c-like [KO:K08738]
121474881  cytochrome c [KO:K08738]
121499929  TP53; cellular tumor antigen p53 [KO:K04451]
121473591  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
121486283  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
121479706  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
121495322  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
121497413  BAK1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
121472218  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
121489193  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
121492863  EGF; pro-epidermal growth factor isoform X1 [KO:K04357]
121490441  TGFA; protransforming growth factor alpha [KO:K08774]
121472687  EREG; proepiregulin [KO:K09784]
121473607  AREG; amphiregulin [KO:K09782]
121471236  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
121473934  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
121491936  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
121493142  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
121472124  HRAS; GTPase HRas isoform X1 [KO:K02833]
121491321  NRAS; GTPase NRas [KO:K07828]
121496713  MTOR; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
121471453  RPS6KB2; ribosomal protein S6 kinase beta-2 isoform X1 [KO:K04688] [EC:2.7.11.1]
121472885  RPS6KB1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Reference
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Hector S, Prehn JH
  Title
Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review.
  Journal
Biochim Biophys Acta 1795:117-29 (2009)
DOI:10.1016/j.bbcan.2008.12.002
Reference
  Authors
Karnoub AE, Weinberg RA
  Title
Ras oncogenes: split personalities.
  Journal
Nat Rev Mol Cell Biol 9:517-31 (2008)
DOI:10.1038/nrm2438
Reference
  Authors
Wang D, Xia D, Dubois RN
  Title
The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer.
  Journal
Cancers (Basel) 3:3894-908 (2011)
DOI:10.3390/cancers3043894
Reference
  Authors
Dasari A, Messersmith WA
  Title
New strategies in colorectal cancer: biomarkers of response to epidermal growth factor receptor monoclonal antibodies and potential therapeutic targets in phosphoinositide 3-kinase and mitogen-activated protein kinase pathways.
  Journal
Clin Cancer Res 16:3811-8 (2010)
DOI:10.1158/1078-0432.CCR-09-2283
Reference
  Authors
Hutchinson RA, Adams RA, McArt DG, Salto-Tellez M, Jasani B, Hamilton PW
  Title
Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer.
  Journal
J Transl Med 13:217 (2015)
DOI:10.1186/s12967-015-0531-z
Related
pathway
vlg04010  MAPK signaling pathway
vlg04012  ErbB signaling pathway
vlg04110  Cell cycle
vlg04115  p53 signaling pathway
vlg04150  mTOR signaling pathway
vlg04151  PI3K-Akt signaling pathway
vlg04210  Apoptosis
vlg04310  Wnt signaling pathway
vlg04350  TGF-beta signaling pathway
KO pathway
ko05210   
LinkDB

DBGET integrated database retrieval system